The DOI matches its Crossref record; 268 of the 268 references it cites were found in a registry or an index.
Cellular and molecular neuropathology of the cuprizone mouse model: Clinical relevance for multiple sclerosis
Open accessAbstract
The cuprizone mouse model allows the investigation of the complex molecular mechanisms behind nonautoimmune-mediated demyelination and spontaneous remyelination. While it is generally accepted that oligodendrocytes are specifically vulnerable to cuprizone intoxication due to their high metabolic demands, a comprehensive overview of the etiology of cuprizone-induced pathology is still missing to date. In this review we extensively describe the physico-chemical mode of action of cuprizone and discuss the molecular and enzymatic mechanisms by which cuprizone induces metabolic stress, oligodendrocyte apoptosis, myelin degeneration and eventually axonal and neuronal pathology. In addition, we describe the dual effector function of the immune system which tightly controls demyelination by effective induction of oligodendrocyte apoptosis, but in contrast also paves the way for fast and efficient remyelination by the secretion of neurotrophic factors and the clearance of cellular and myelinic debris. Finally, we discuss the many clinical symptoms that can be observed following cuprizone treatment, and how these strengthened the cuprizone model as a useful tool to study human multiple sclerosis, schizophrenia and epilepsy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Importantly this apoptosis precedes the massive demyelination caused by cuprizone administration [18], indicating that oligodendrocyte degeneration is the main cause, as opposed to a secondary immune response.”
From Strain differences in cuprizone induced demyelination (2017) · cites this paper as [18]
In the citing paper
“In addition to the direct effect of cuprizone on oligodendrocytes, the involvement of the brain’s resident neuroinflammatory cells such as microglia and astrocyes is also believed to be responsible for the massive demyelination occurring at 4 weeks time point of cuprizone exposure [18].”
From Strain differences in cuprizone induced demyelination (2017) · cites this paper as [18]
In the citing paper
“Nevertheless, a consensus seems to be that cuprizone selectively affects oligodendrocytes.”
From Strain differences in cuprizone induced demyelination (2017) · cites this paper as [18]
In the citing paper
“Astrocytes and microglia collaborate through the release of cytokines, chemokines, and other, yet to be identified factors, to drive demyelination [79, 107], preventing the release of specific cytokines or chemokines, restricting astrocyte reactivity, or ablating microglia all reduce cuprizone-induced demyelination [107, 181, 189, 243].”
From Oligodendrocyte death and myelin loss in the cuprizone model: an updated overview of the intrinsic and extrinsic causes of cuprizone demyelination (2022) · cites this paper as [107]
In the citing paper
“The cuprizone model is based on oral ingestion of the copper chelator cuprizone, causing metabolic oligodendrocyte injury.”
From Insights and challenges on animal models for progressive multiple sclerosis (2026) · cites this paper as [183]
In the citing paper
“These include cuprizone (CUP), a chemical toxin, which when provided in the diet of adult mice results in reliable demyelination of the corpus callosum (CC). Upon removal of CUP from the diet, there is robust remyelination (Matsushima & Morrell, 2001; Praet, et al, 2014; Wergeland, Torkildsen, Myhr, Mørk, & Bø et al, 2012).”
From Activated microglia drive demyelination via CSF1R signaling (2021) · cites this paper as Praet, et al, 2014
In the citing paper
“In the following chapter we will briefly introduce the cuprizone model, a toxin-induced demyelination model [21,22].”
From The Cuprizone Model: Dos and Do Nots (2020) · cites this paper as [22]
In the citing paper
“Oral intoxication with the copper-chelator cuprizone induces oligodendrocyte apoptosis within a few days, which is closely followed by the activation of the innate immune cells in the brain, i.e., astrocytes and microglia, finally leading to demyelination of distinct white and grey matter brain areas.”
From The Cuprizone Model: Dos and Do Nots (2020) · cites this paper as [22]
In the citing paper
“Mitochondrial injury and oxidative stress are believed to be fundamental elements of CPZ induced pathology (66).”
From Absence of miRNA-146a Differentially Alters Microglia Function and Proteome (2020) · cites this paper as [66]
Citations
Cites
Endoplasmic reticulum stress: cell life and death decisions
Xu, C. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26373 · Cited by 2,291
Biology of Oligodendrocyte and Myelin in the Mammalian Central Nervous System
Baumann, N., & Pham-Dinh, D. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.871 · Cited by 1,828
Demyelination increases radial diffusivity in corpus callosum of mouse brain
Song, S.-K., Yoshino, J., Le, T. Q., Lin, S.-J., Sun, S.-W., Cross, A. H., & Armstrong, R. C. (2005) · NeuroImage · doi:10.1016/j.neuroimage.2005.01.028 · Cited by 1,658
Endoplasmic Reticulum Stress and Oxidative Stress: A Vicious Cycle or a Double-Edged Sword?
Malhotra, J. D., & Kaufman, R. J. (2007) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1782 · Cited by 1,588
The yin and yang of neurotrophin action
Lu, B., Pang, P. T., & Woo, N. H. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1726 · Cited by 1,356
Bak, L. K., Schousboe, A., & Waagepetersen, H. S. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03913.x · Cited by 1,114
Debris clearance by microglia: an essential link between degeneration and regeneration
Neumann, H., Kotter, M. R., & Franklin, R. J. M. (2008) · Brain · doi:10.1093/brain/awn109 · Cited by 1,111
TNFα promotes proliferation of oligodendrocyte progenitors and remyelination
Arnett, H. A., Mason, J., Marino, M., Suzuki, K., Matsushima, G. K., & Ting, J. P.-Y. (2001) · Nature Neuroscience · doi:10.1038/nn738 · Cited by 1,012
Matsushima, G. K., & Morell, P. (2001) · Brain Pathology · doi:10.1111/j.1750-3639.2001.tb00385.x · Cited by 984
Myelin Impairs CNS Remyelination by Inhibiting Oligodendrocyte Precursor Cell Differentiation
Kotter, M. R., Li, W.-W., Zhao, C., & Franklin, R. J. M. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.2615-05.2006 · Cited by 768
Cited by
Sorted by citations
Items 301–400 of 435
The Kappa Opioid Receptor: Candidate Pharmacotherapeutic Target for Multiple Sclerosis
Reed, B., & Dutta, S. (2023) · Drugs and Drug Candidates · doi:10.3390/ddc2040044 · Cited by 4
Zarini, D., Pasbakhsh, P., Mojaverrostami, S., Amirizadeh, S., Hashemi, M., Shabani, M., Noshadian, M., & Kashani, I. R. (2024) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2023.101630 · Cited by 5
Kushwaha, S., Saji, J., Verma, R., Singh, V., Ansari, J. A., Mishra, S. K., Roy, O., Patnaik, S., & Ghosh, D. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-03978-z · Cited by 4
Polyák, H., Galla, Z., Rajda, C., Monostori, P. B., Klivènyi, P., & Vécsei, L. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26030976 · Cited by 4
Melatonin ameliorates astrogliosis and microgliosis in a cuprizone demyelinating mouse model
Alidadi, M., Omidi, N., Abdi, M., Mohammadi, M., Shabani, M., & Kashani, I. R. (2025) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2025.101929 · Cited by 4
PART 2: Mouse models for multiple sclerosis research
Ramasamy, R., & Smith, P. P. (2021) · Neurourology and Urodynamics · doi:10.1002/nau.24654 · Cited by 4
Recombinant lectin Gg for brain imaging of glycan structure and formation in the CNS node of Ranvier
Tulin, E. K. C., Yoshimura, T., Nakazawa, C., Saito, S., Kanai, K., Kozono, T., Nakakita, S., Tonozuka, T., Ikenaka, K., & Nishikawa, A. (2022) · Journal of Neurochemistry · doi:10.1111/jnc.15695 · Cited by 3
Cell‐based experimental strategies for myelin repair in multiple sclerosis
Borda, M., Aquino, J. B., & Mazzone, G. L. (2022) · Journal of Neuroscience Research · doi:10.1002/jnr.25129 · Cited by 4
Alavi, O., Alizadeh, A. A., Dehghani, F., Alipour, H., & Tanideh, N. (2023) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x18666230228102731 · Cited by 4
Roles of Adenosine Receptor (subtypes A1 and A2A) in Cuprizone-Induced Hippocampal Demyelination
Adebiyi, O. E., & Bynoe, M. S. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03440-6 · Cited by 5
Labunets, І. F. (2020) · Izdevniecība “Baltija Publishing” eBooks · doi:10.30525/978-9934-588-44-0/18 · Cited by 4
Labunets, І. F., Utko, N. A., & Toporova, O. K. (2021) · Advances in Gerontology · doi:10.1134/s2079057021020077 · Cited by 4
Marzan, D. E., West, B. L., & Salzer, J. L. (2018) · doi:10.1101/501148 · Cited by 4
Hilton, J. B. W., Kysenius, K., Liddell, J. R., Mercer, S. W., Rautengarten, C., Hare, D. J., Buncic, G., Paul, B. T., Murray, S. S., McLean, C., et al. (2024) · Neurotherapeutics · doi:10.1016/j.neurot.2024.e00432 · Cited by 4
Sun, R., Ma, T., Zhao, Z., Gao, Y., Feng, J., & Yang, X. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70111 · Cited by 3
Martínez‐Pinilla, E., Rubio-Sardón, N., Fernández-García, G., Villar‐Conde, S., Menéndez-Pérez, C., Tolivia, J., del Valle, E., & Navarro, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178692 · Cited by 3
Neurotherapeutic impact of vanillic acid and ibudilast on the cuprizone model of multiple sclerosis
Alderbi, R. M., Alam, M. Z., Alghamdi, B., Alsufiani, H., El-Aziz, G. A. A., Omar, U. M., & Al-Ghamdi, M. A. (2025) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2024.1503396 · Cited by 2
Implementation of a toxic cuprizone model of demyelination in vitro
Rodnichenko, A. E. (2018) · Cell and Organ Transplantology · doi:10.22494/cot.v6i1.84 · Cited by 3
Labunets, І. F., Rodnichenko, A. E., Melnyk, N. O., & Utko, N. (2018) · Cell and Organ Transplantology · doi:10.22494/cot.v6i2.87 · Cited by 3
Gakare, S. G., Bhatt, J. M., Narasimhan, K. K. S., & Dravid, S. M. (2023) · PLoS ONE · doi:10.1371/journal.pone.0294583 · Cited by 4
Shiyu, C., Liu, S., Huang, Y., Huang, S., Zhang, W., Xie, H., & Lu, L. (2024) · Brain and Behavior · doi:10.1002/brb3.3487 · Cited by 3
Tekşen, Y., Özatik, F. Y., & Özatik, O. (2025) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.1007/s44411-025-00129-1 · Cited by 4
Tahmasebi, F., Asl, E. R., Faghihi, F., Bolandi, N., & Barati, S. (2025) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-025-01558-w · Cited by 3
Pringproa, K., Sathanawongs, A., Chananthida, K., Sarocha, S., & Oranratnachai, A. (2016) · Neural Regeneration Research · doi:10.4103/1673-5374.193239 · Cited by 3
Assessment of 18F-PBR-111 in the Cuprizone Mouse Model of Multiple Sclerosis
Jewells, V. L., Yuan, H., Merrill, J. R., Frank, J. E., Patel, A., Cohen, S. M., Giglio, B. C., Feinberg, N. N., Matsushima, G. K., & Li, Z. (2021) · Diagnostics · doi:10.3390/diagnostics11050786 · Cited by 4
Sajedi, D., Shabani, R., & Elmieh, A. (2021) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12673 · Cited by 3
Ramasamy, R., Hardy, C. C., Crocker, S. J., & Smith, P. P. (2022) · Journal of Neuroscience Research · doi:10.1002/jnr.25065 · Cited by 3
Kanno, T., Kurotaki, T., YAMADA, N., Tomonari, Y., Sato, J., Tsuchitani, M., & KOBAYASHI, Y. (2019) · Journal of Veterinary Medical Science · doi:10.1292/jvms.19-0096 · Cited by 3
Changes to Astrocyte-associated Protein Expression at Different Timepoints of Cuprizone TreatmentPreprint
Frankle, L., Riley, A., Tomor, R., Lee, H., Jarzembak, K., Benedict, O., Sternbach, S., Shelestak, J., McDonough, J. A., & Clements, R. J. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.04.20.537627 · Cited by 3
Alyami, K. A., Alshahrany, G. A., Al-Otaibi, K. M., Alam, M. Z., Alghamdi, B. S. A., Alsufiani, H. M., Alshareef, N. O., Alhoraibi, H., Alkhodair, S. A., & Omar, U. M. (2025) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2025.1567226 · Cited by 2
Zolfaghari, A., Omidi, A., & Soodi, M. (2025) · Metabolic Brain Disease · doi:10.1007/s11011-025-01676-w · Cited by 2
Orhan, M. D., Oktay, L., Cınar, A. I., Yesil, A. K., Tunç, H., Eren, F., Durdağı, S., & Avsar, T. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5c00519 · Cited by 2
Alam, M. Z., Bagabir, H. A., Zaher, M. A. F., Alqurashi, T. M. A., Alghamdi, B. S. A., Kazi, M., El-Aziz, G. S. A., Alshahrany, G. A., Alzahrani, N. A., Bakhalgi, R. M., et al. (2025) · Pharmaceuticals · doi:10.3390/ph18101478 · Cited by 2
Pinto, L. I. G., Adamo, A. M., & Mathieu, P. (2025) · BioFactors · doi:10.1002/biof.70051 · Cited by 2
Lin, M. L., & Lin, W. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27041779 · Cited by 2
Early-Age Cuprizone Exposure Induces Region-Specific Demyelination and Neuroinflammation in Mice
Rokach, M., Levy, G., Elad‐Sfadia, G., & Barak, B. (2026) · NeuroMolecular Medicine · doi:10.1007/s12017-026-08911-2 · Cited by 2
A review of MRI evaluation of demyelination in cuprizone murine model
Павловна, К. Е., Pan, E. S., & Khodanovich, M. Y. (2015) · AIP conference proceedings · doi:10.1063/1.4935998 · Cited by 2
Multiple sclerosis and neuromyelitis optica spectrum disorders
Ionescu, R.-B., Willis, C. M., Nicaise, A. M., Krzak, G., Hamel, R., Peruzzotti‐Jametti, L., & Pluchino, S. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85654-6.00051-4 · Cited by 2
Beliard, B., Delay, L., Travert-Jouanneau, Y., Travert-Jouanneau, Y., Ialy-Radio, N., Goazigo, A. R.-L., Deffieux, T., Bradley, D. P., Tanter, M., & Pezet, S. (2025) · Imaging Neuroscience · doi:10.1162/imag_a_00534 · Cited by 2
Ricciardi, L., Marco, F. D., Decrop, M., Stefano, J. D., Kakunuri, T., van Rijswijk, J., Vidas-Guscic, N., Ouaamari, Y. E., Bufi, A. A., Spilbeeck, I. V., et al. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03569-2 · Cited by 2
Self-citationLabunets, І. F., Rodnichenko, A. E., Utko, N., Panteleimonova, T. N., Pokholenko, Y. O., Litoshenko, Z., & Butenko, G. M. (2019) · Cell and Organ Transplantology · doi:10.22494/cot.v7i1.93 · Cited by 2
Turning White Matter “Inside-Out” by Hyper-deimination of Myelin Basic Protein (MBP)
Harauz, G. (2017) · Springer eBooks · doi:10.1007/978-3-319-58244-3_19 · Cited by 2
Kostadinova, I., Landzhov, B. V., Marinov, L., Vezenkov, L. T., & Danchev, N. D. (2021) · Amino Acids · doi:10.1007/s00726-021-03035-2 · Cited by 2
Dapsone reduced cuprizone-induced demyelination via targeting Nrf2 and IKB in C57BL/6 mice.
Dehpour, A. R., Khaledi, E., Noori, T., Mohammadi-Farani, A., Delphi, L., Sureda, A., Sobarzo‐Sánchez, E., & Shirooie, S. (2022) · PubMed Central · doi:10.22038/ijbms.2022.64993.14310 · Cited by 2
Labunets, І. F., Utko, N., Panteleymonova, T. N., Kyryk, V. M., Kharkevych, Y. O., Rodnichenko, A. E., Litoshenko, Z., & Butenko, G. M. (2022) · Cell and Organ Transplantology · doi:10.22494/cot.v10i1.134 · Cited by 2
O'Loughlin, E. K., Jacob, B., Zeballos, G., Manfre, P., McCullough, A., Gatto, N. T., Tsuchiya, T., Kärkkäinen, A., Lehtimäki, K. K., Kuosmanen, J., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.12.17.423334 · Cited by 2
Tsai, H., Piya, S., Wang, J., Zhu, J. K., Hu, W., Gehrke, A. R., Cao, S., Guise, A. J., Chan, S. J., Sheehan, M. J., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.02.07.637125 · Cited by 2
Insights and challenges on animal models for progressive multiple sclerosis
Nalepa, I. F., Haahr, N. O., Bekiaris, V., Jakobsen, M. R., Asuni, A. A., & Benmamar-Badel, A. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-03805-3 · Cited by 1
Farhadifard, G., Haddadi, R., Sanemar, K., Farhadifard, H., & Mohammadi, M. (2023) · Current Drug Therapy · doi:10.2174/1574885518666230512120450 · Cited by 1
Rahamathulla, M., Kumar, R., Alrashdan, Y., Bose, M. M., Muthukumar, A., Salahuddin, M., Ahmed, M. M., Shivanandappa, T. B., & Pasha, I. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-04934-1 · Cited by 2
Lang, J., Zhou, W., Huang, T., Jiang, H., Chen, H., Xu, S., Qiu, L., Heady, M., Yu, Y., Brier, M. R., et al. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c00881 · Cited by 1
Self-citationSalama, A., Darwish, A. B., El-Shenawy, S. M. A., & Wagdi, M. A. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.126204 · Cited by 1
Kolo, R. M., Ehirim, C. B., Olabiyi, D. O., Ayobamidele, I. A., Jaji‐Sulaimon, R., & Omotoso, G. O. (2025) · Multiple Sclerosis Journal - Experimental Translational and Clinical · doi:10.1177/20552173251405050 · Cited by 1
Qiu, L., Zhou, W., Chen, H., Jiang, H., Lang, J., Xing, Z., Heady, M., Gropler, R. J., Guglielmetti, C., Perlmutter, J. S., et al. (2025) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2025.118536 · Cited by 1
Self-citationMisfolding protein pathology detected in a chronic mouse model of multiple sclerosis
MacKeigan, T. P., Morgan, M. L., Mitchell, S., & Stys, P. K. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.12.063 · Cited by 1
Altered serotonergic system and mood behaviors in a cuprizone-induced model of demyelination
Souhoudji, T. D., Ouard, N., Bah, A. A., Tali, A., Jebbouj, R., Kipp, M., & Ahboucha, S. (2026) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2026.106991 · Cited by 1
Sobel, R. A., Hinojoza, J., & Zoabi, M. (2026) · Journal of Neuropathology and Experimental Neurology · doi:10.1093/jnen/nlag018
Cannabinoid CB1 receptors drive oligodendrocyte maturation during myelin regeneration
Ezquerro, S., Torre, A. S.-D. L., Monory, K., Lutz, B., Guzmán, M., Aguado, T., & Palazuelos, J. (2026) · Cell Communication and Signaling · doi:10.1186/s12964-026-02852-w · Cited by 1
Metabolic Symbiosis and Vulnerability in the CNS Axon-Myelin Unit
Miao, K., Meng, M., Liu, L., Li, M., Bai, Y., Guo, Y., Zhang, G., Kong, J., & Mu, J. (2026) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-026-01729-3 · Cited by 1
Oxidative Stress and Neurodegeneration
Pasquini, J. M., Pasquini, L. A., & Quintá, H. R. (2016) · Springer eBooks · doi:10.1007/978-3-319-45865-6_20 · Cited by 1
Labunets, І. F., Utko, N., Toporova, O. K., Pokholenko, I., Panteleymonova, T. N., Litoshenko, Z., & Butenko, G. M. (2021) · Cell and Organ Transplantology · doi:10.22494/cot.v9i1.116 · Cited by 2
Relative Molecular Similarity in Compound Structures Modulating Neurodegenerative Apoptosis
Williams, W. R. (2023) · Journal of Biosciences and Medicines · doi:10.4236/jbm.2023.112008 · Cited by 1
Mitra, N. K., Chan, Y., Chellian, J., & Gnanou, J. V. (2023) · International journal of Nutrition Pharmacology Neurological Diseases · doi:10.4103/ijnpnd.ijnpnd_26_23 · Cited by 1
EAAT3 modulation: A potential novel avenue towards remyelination in multiple sclerosis
van Veggel, L., Schepers, M., Tiane, A., Kumar, V., Willems, E., Rombaut, B., Noordijk, J., Vangansewinkel, T., Li, A., Wolfs, E., et al. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.117960 · Cited by 1
Glatiramer–diclofenac nanocomplex enhances remyelination in a mouse model of multiple sclerosis
Aldhabi, B. M., Asfour, H. Z., Okbazghi, S. Z., Al-Rabia, M. W., Alhakamy, N. A., Sirwi, A., Badr-Eldin, S. M., Abdel‐Naim, A. B., & Ashour, O. M. (2025) · Future Journal of Pharmaceutical Sciences · doi:10.1186/s43094-025-00809-3 · Cited by 1
Naghibzadeh, M., ranjbar, R., Tabandeh, M. R., & Habibi, A. (2019) · journal of ilam university of medical sciences · doi:10.29252/sjimu.27.1.122 · Cited by 1
Botz, B., Bátai, I. Z., Kiss, T., Pintér, E., Helyes, Z., & Bölcskei, K. (2019) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2019.12.009 · Cited by 1
Microglial LRP1 modulates neuroinflammation via control of the NF-κB pathway in autoimmunity
Chuang, T. Y. (2016) · doi:10.18130/v3h31c · Cited by 1
Mechanisms for Extracellular Matrix-Dependent Blood-Brain Barrier Dysfunction
Hoettles, B. A. (2021) · doi:10.18122/td/1903/boisestate · Cited by 1
Gurubarath, M., & Dhananjayan, K. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.12.10.570981 · Cited by 1
Immunopathogenesis of cortical demyelination in Multiple Sclerosis
Lagumersindez-Denis, N. (2015) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-5375
Animal Models in Neuro Ophthalmology
Normando, E. M., Brodie, J. T., & Cordeiro, M. F. (2016) · Springer eBooks · doi:10.1007/978-3-319-24085-5_13
Templeton, N. (2017) · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare) · doi:10.26686/wgtn.17060486.v1
McMurran, C. E., de la Fuente, A. G., Peñalva, R. G., Menachem-Zidon, O. B., Dombrowski, Y., González, G. A., Zhao, C., Krause, F. N., Young, A. M. H., Griffin, J. L., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/575829
Experimental In Vivo Models for Drug Discovery in Multiple Sclerosis
Mestre, L., & Guaza, C. (2019) · Royal Society of Chemistry eBooks · doi:10.1039/9781788016070-00088
Innate Immune Responses in Human Oligodendrocytes
Saito, L. B. (2019) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3-119j-zq43
Characterising the role of AMIGO3 in oligodendrocytes and demyelinating diseases
Foale, S. (2019) · University of Birmingham Institutional Research Archive (University of Birmingham)
The role of the astrocytic and microglial aryl hydrocarbon receptor in CNS demyelination
Schmid, S. (2020) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-8335
Cholesterol metabolism in mouse models of Multiple Sclerosis
Berghoff, S. A. (2020) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-8239
Alrashdi, B. M. (2021) · DalSpace (Dalhousie University)
Almuslehi, M. S. M., Sen, M. K., Shortland, P. J., Mahns, D. A., & Coorssen, J. R. (2021) · Research Square · doi:10.21203/rs.3.rs-1129433/v1
Papazian, I., Tsoukala, E., Καραμίτα, Μ., Boutou, A., Iliopoulou, L., Kambas, K., Fischer, R., Kontermann, R. E., Denis, M. C., Kollias, G. A., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-136877/v1
Animal Models in Neuro Ophthalmology
Normando, E. M., & Cordeiro, M. F. (2020) · Springer eBooks · doi:10.1007/978-3-030-26269-3_19
Effects of dimethyl fumarate in two animal models of MS
Traffehn, S. (2017) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-6275
Acupuncture Treatment for Multiple Sclerosis
Wang, J., & Wu, S. (2022) · Springer eBooks · doi:10.1007/978-3-030-96221-0_20
Molinari, Y. A., Byrne, A. J., Pérez, M. J., Silvestroff, L., & Franco, P. G. (2022) · Research Square · doi:10.21203/rs.3.rs-1636865/v1
Marzban, M., Rustamzadeh, A., Asghari, A., Terme, Y., Amichi, A. G., Ghanbarzehi, V., Holaso, A. S., Hosseini, F., Shahraki, M., Sadafi, P., et al. (2022) · Acta Histochemica · doi:10.1016/j.acthis.2022.151953
Animal models of multiple sclerosis and the lower urinary tract
Ramasamy, R., Crocker, S. J., & Smith, P. P. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-89833-1.00009-4
Öztürk, S., Aytaç, G., Karadas, A. K., Danışman, B., Tanrιöver, G., Derin, N., Akkoyunlu, G., Kızılay, F., & Sındel, M. (2023) · Journal of Anatomical Society of India · doi:10.4103/jasi.jasi_144_21
An In Vivo Accelerated Developmental Myelination Model for Testing Promyelinating Therapeutics
Lariosa-Willingham, K. D., Leonoudakis, D., Bragge, T., Tolppanen, L., Nurmi, A., Flanagan, M., Gibson, J., Wilson, D. L., Stratton, J., Lehtimäki, K. K., et al. (2023) · Vide Leaf, Hyderabad eBooks · doi:10.37247/pans2ed.2.22.10
Abadey, A. A. (2023) · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare) · doi:10.26686/wgtn.23639313
Beliard, B., Delay, L., Rivals, I., Travert-Jouanneau, Y., Ialy-Radio, N., Goazigo, A. R.-L., Deffieux, T., Bradley, D. P., Tanter, M., & Pezet, S. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.03.18.585596
Venediktov, A. A., Александрович, К. Е., Pokidova, K., Oganesyan, D., Stepanian, A. T., Boronikhina, T. V., Piavchenko, G. A., & Kuznetsov, S. L. (2024) · Molekulyarnaya Meditsina (Molecular medicine) · doi:10.29296/24999490-2024-05-02 · Cited by 1
Tsukuda, K., Tominaga, Y., Taketoshi, M., Miwa, M., Nakashima, K., & Tominaga, T. (2025) · eNeuro · doi:10.1523/eneuro.0511-24.2024 · Cited by 1
Animal Models in Neuro Ophthalmology
Normando, E. M., Sher, A., Patel, R. P., Arora, N., & Cordeiro, M. F. (2025) · Springer eBooks · doi:10.1007/978-3-031-72156-4_19
Metadata
- Authors
- Praet, J., Guglielmetti, C., Berneman, Z., Van der Linden, A., & Ponsaerts, P.
- Affiliations
- University of Antwerp (BE)
- Corresponding author
- Praet, Jelle
- Venue
- Neuroscience & Biobehavioral Reviews
- Publisher
- Elsevier BV
- Published
- 2014-11
- Volume
- 47
- Pages
- 485-505
- ISSN
- 0149-7634 (ISSN-L)
- OpenAlex
- W1991883207
- Cited by
- 435
- References
- 268
- Citations by year
- 2026: 29 · 2025: 36 · 2024: 29 · 2023: 37 · 2022: 51 · 2021: 49 · 2020: 48 · 2019: 49 · 2018: 41 · 2017: 35 · 2016: 19 · 2015: 12
- FWCI
- 3.11
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Neuroscience & Biobehavioral Reviews (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Fund for Scientific Research-Flanders
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- cuprizone, multiple sclerosis, demyelination, remyelination, oligodendrocyte apoptosis, myelin degeneration, metabolic stress, neuroinflammation, neurotrophic factors, myelin debris clearance, axonal pathology, neuronal pathology, schizophrenia, epilepsy, mouse model
- MeSH terms
- Animals, Brain, Cuprizone, Disease Models, Animal, Multiple Sclerosis, Myelin Sheath, Neuroglia, Neurons, Oxidative Stress, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
